Contact information

Registered office:

Head Office
Vernalis plc
100 Berkshire Place
Wharfedale Road
Winnersh, RG41 5RD, UK

t: +44 (0)118 938 0000
f: +44 (0)118 938 0001

 

Also at:

UK:

Vernalis (R&D) Ltd
Granta Park
Cambridge, CB21 6GB, UK

t: +44 (0)1223 895555
f: +44 (0)1223 895556

US: 

Vernalis Therapeutics, Inc.
Suite 100, 1160 W Swedesford Road
Berwyn, PA 19312, USA

t: +1 484 913 0700
f: +1 610 651 5976

 

If you require medical information on any of our products please email medical@vernalis.com

Latest News

Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration

Servier and Vernalis plc are pleased to announce the achievement of two research milestones and one clinical milestone in their oncology drug discovery collaboration, triggering a total payment of €2 million to Vernalis.

 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch